Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg/vial - azithromycin - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - powder for suspension - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms :in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - powder for suspension - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms : in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - azithromycin - powder for suspension - azithromycin 2.096 g - azithromycin - azithromycin - zmax is indicated for the treatment of patients 18 years of age and above with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. adults: acute bacterial sinusitis due to haemophilus influenzae moraxella catarrhalis or streptococcus pneumoniae. community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - azithromycin dihydrate - capsules hard - 250 milligram - macrolides

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate - for microspheres - granule, for suspension, extended release - 2.096 g/bottle

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin (as azithromycin dihydrate) - injection, powder, for solution - 100 mg/ml - azithromycin (as azithromycin dihydrate) 100 mg/ml

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate eqv azithromycin - tablet, film coated - 250 mg - azithromycin dihydrate eqv azithromycin 250 mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate eqv azithromycin - tablet, film coated - 500 mg - azithromycin dihydrate eqv azithromycin 500 mg

Singapore - English - HSA (Health Sciences Authority)

pfizer private limited - azithromycin dihydrate eqv azithromycin - tablet, film coated - 600 mg - azithromycin dihydrate eqv azithromycin 600 mg